FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981972038> ?p ?o ?g. }

• W2981972038 endingPage "341" @default.
• W2981972038 startingPage "337" @default.
• W2981972038 abstract "Ever since evidence about the increased risk of stent thrombosis with drug eluting stents (DES) surfaced in 2005, the Food and Drug Administration (FDA) has recommended the use of dual antiplatelet therapy (aspirin with P2Y12 inhibitor) following DES placement. The PLATO trial demonstrated lower mortality rates with the use of Ticagrelor when compared to clopidogrel (9.8% vs. 11.7%, p<0.001) when treating patients with acute coronary syndrome. Given their pleiotropic benefits, statins are today the second most prescribed drug in the United States and often co-prescribed with Ticagrelor. FDA's post market surveillance of Ticagrelor use along with statins in post-myocardial infarction care is now revealing novel and serious adverse events. We present two cases of rhabdomyolysis and acute renal failure (ARF) which develop while the patients were on statins and Ticagrelor. Case 1: A 66-year-old female presented with bilateral thigh pain for 3 days. One month prior to presentation, she was managed for non-ST segment elevation myocardial infarction (NSTEMI) and had been started on aspirin, ticagrelor and simvastatin. Laboratory values revealed creatinine kinase (CK) level at 40,000 U/L and creatinine 3.2 mg/dL suggesting rhabdomyolysis and ARF. Case 2: A 63-year-old male presented with generalized body aches and fatigue for 4 days. He had sustained STEMI two months before and received two drug eluting stents (DES) and aspirin, ticagrelor and rosuvastatin had been initiated. CK was 380,000 U/L and creatinine 7.94 mg/dL suggesting rhabdomyolysis and ARF. Both patients presented with rhabdomyolysis and acute renal failure within weeks after ticagrelor and statin were commenced. A review of the literature indicated that 11 similar cases of ticagrelor-induced ARF and rhabdomyolysis had been reported. Ticagrelor competes with statins when metabolized by cytochrome P450 (CYP) 3A4 leading to statin retention, leading to major adverse effects like rhabdomyolysis and acute renal failure. Our review is intended to alert clinicians about this important drug interaction." @default.
• W2981972038 created "2019-11-01" @default.
• W2981972038 creator A5008842438 @default.
• W2981972038 creator A5010059162 @default.
• W2981972038 creator A5015559144 @default.
• W2981972038 creator A5018074715 @default.
• W2981972038 creator A5058368726 @default.
• W2981972038 creator A5062245405 @default.
• W2981972038 creator A5067313194 @default.
• W2981972038 creator A5071480133 @default.
• W2981972038 creator A5072463170 @default.
• W2981972038 date "2019-10-20" @default.
• W2981972038 modified "2023-10-16" @default.
• W2981972038 title "Ticagrelor and Statin Interaction Induces Rhabdomyolysis and Acute Renal Failure: Case reports and Scoping Review" @default.
• W2981972038 cites W1433049918 @default.
• W2981972038 cites W1487609 @default.
• W2981972038 cites W1511974464 @default.
• W2981972038 cites W1553345686 @default.
• W2981972038 cites W1974005985 @default.
• W2981972038 cites W1981254493 @default.
• W2981972038 cites W1982914740 @default.
• W2981972038 cites W1996664577 @default.
• W2981972038 cites W2010033213 @default.
• W2981972038 cites W2055105660 @default.
• W2981972038 cites W2059078444 @default.
• W2981972038 cites W2074324898 @default.
• W2981972038 cites W2099355565 @default.
• W2981972038 cites W2107797912 @default.
• W2981972038 cites W2107969192 @default.
• W2981972038 cites W2115093986 @default.
• W2981972038 cites W2121178468 @default.
• W2981972038 cites W2134159541 @default.
• W2981972038 cites W2168722424 @default.
• W2981972038 cites W2253702257 @default.
• W2981972038 cites W2487995191 @default.
• W2981972038 cites W2519430929 @default.
• W2981972038 cites W2580776577 @default.
• W2981972038 cites W2619647479 @default.
• W2981972038 cites W2750791268 @default.
• W2981972038 cites W2768744559 @default.
• W2981972038 cites W2780042637 @default.
• W2981972038 cites W2791721280 @default.
• W2981972038 cites W2799514315 @default.
• W2981972038 cites W2879045439 @default.
• W2981972038 cites W2900034165 @default.
• W2981972038 cites W3006057482 @default.
• W2981972038 doi "https://doi.org/10.12691/ajmcr-7-12-9" @default.
• W2981972038 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6863346" @default.
• W2981972038 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31745500" @default.
• W2981972038 hasPublicationYear "2019" @default.
• W2981972038 type Work @default.
• W2981972038 sameAs 2981972038 @default.
• W2981972038 citedByCount "13" @default.
• W2981972038 countsByYear W29819720382020 @default.
• W2981972038 countsByYear W29819720382021 @default.
• W2981972038 countsByYear W29819720382022 @default.
• W2981972038 countsByYear W29819720382023 @default.
• W2981972038 crossrefType "journal-article" @default.
• W2981972038 hasAuthorship W2981972038A5008842438 @default.
• W2981972038 hasAuthorship W2981972038A5010059162 @default.
• W2981972038 hasAuthorship W2981972038A5015559144 @default.
• W2981972038 hasAuthorship W2981972038A5018074715 @default.
• W2981972038 hasAuthorship W2981972038A5058368726 @default.
• W2981972038 hasAuthorship W2981972038A5062245405 @default.
• W2981972038 hasAuthorship W2981972038A5067313194 @default.
• W2981972038 hasAuthorship W2981972038A5071480133 @default.
• W2981972038 hasAuthorship W2981972038A5072463170 @default.
• W2981972038 hasBestOaLocation W29819720381 @default.
• W2981972038 hasConcept C126322002 @default.
• W2981972038 hasConcept C164705383 @default.
• W2981972038 hasConcept C2776329913 @default.
• W2981972038 hasConcept C2776839432 @default.
• W2981972038 hasConcept C2777482532 @default.
• W2981972038 hasConcept C2777628954 @default.
• W2981972038 hasConcept C2777698277 @default.
• W2981972038 hasConcept C2777849778 @default.
• W2981972038 hasConcept C2779379848 @default.
• W2981972038 hasConcept C2780499067 @default.
• W2981972038 hasConcept C2780890252 @default.
• W2981972038 hasConcept C500558357 @default.
• W2981972038 hasConcept C71924100 @default.
• W2981972038 hasConceptScore W2981972038C126322002 @default.
• W2981972038 hasConceptScore W2981972038C164705383 @default.
• W2981972038 hasConceptScore W2981972038C2776329913 @default.
• W2981972038 hasConceptScore W2981972038C2776839432 @default.
• W2981972038 hasConceptScore W2981972038C2777482532 @default.
• W2981972038 hasConceptScore W2981972038C2777628954 @default.
• W2981972038 hasConceptScore W2981972038C2777698277 @default.
• W2981972038 hasConceptScore W2981972038C2777849778 @default.
• W2981972038 hasConceptScore W2981972038C2779379848 @default.
• W2981972038 hasConceptScore W2981972038C2780499067 @default.
• W2981972038 hasConceptScore W2981972038C2780890252 @default.
• W2981972038 hasConceptScore W2981972038C500558357 @default.
• W2981972038 hasConceptScore W2981972038C71924100 @default.
• W2981972038 hasIssue "12" @default.
• W2981972038 hasLocation W29819720381 @default.
• W2981972038 hasLocation W29819720382 @default.
• W2981972038 hasLocation W29819720383 @default.

• next